DYRK1B and cancer: The survival kinase DYRK1B (dual-specificity tyrosine phosphorylation-regulated kinase 1B) has been shown to be upregulated in dormant cancer cells, promoting dormancy by stabilizing the CDK inhibitor and inducing the degradation of cyclin D [65].